Trial
NCT01274221
Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Shire
Collaborators
—
Condition
ADHD
Intervention
SPD489
Why stopped
Cancellation was not safety related but a shift in study priorities for Shire.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-03